AI assistant
Sending…
IRADIMED CORP — Director's Dealing 2022
Jan 4, 2022
32324_dirs_2022-01-04_472278e8-07d0-4ac4-ba8c-024aba632d75.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: IRADIMED CORP (IRMD)
CIK: 0001325618
Period of Report: 2021-12-27
Reporting Person: Susi Roger E. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-12-27 | Common Stock | G | 22600 | — | Disposed | 803450 | Indirect |
| 2021-12-27 | Common Stock | G | 500 | — | Disposed | 802950 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2362500 | Indirect |
| Common Stock | 2362500 | Indirect |
Footnotes
F1: The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all the reported shares for purposes of Section 16 or for any other purpose.
More from IRADIMED CORP
Interim / Quarterly Report
2026
May 1
Annual Report
2026
Apr 30
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Feb 13
Regulatory Filings
2026
Feb 10
Major Shareholding Notification
2026
Feb 10
Director's Dealing
2026
Jan 27
Director's Dealing
2026
Jan 21
Director's Dealing
2026
Jan 13
Director's Dealing
2026
Jan 6